William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Articles
Following the Patent Dance Three Years After Sandoz
USA - May 28 2019 In June 2017, the Supreme Court handed down its decision in Sandoz v. Amgen—the first lawsuit brought under the Biologics Price Competition and…
Inherency in Obviousness—A Worrying Trend?
USA - April 13 2018 Anticipation by inherency is a well-recognized, and generally well-understood, patent law doctrine. A prior art reference may anticipate an…
CAFC and SCOTUS Take First Look at Provisions of BPCIA in Amgen v. Sandoz
USA - January 12 2018 In Amgen Inc. v. Sandoz Inc., 794 F.3d 1347 (Fed. Cir. 2015), the CAFC affirmed the district court’s interpretation of the “information exchange”…
“A riddle wrapped in a mystery inside an enigma”: the Federal Circuit attempts to decode the BPCIA
USA - July 27 2015 On July 21, 2015, the Federal Circuit issued a divided decision in Amgen Inc. v. Sandoz Inc., No. 15-1499 (Fed. Cir. July 21, 2015), interpreting two…
Federal Circuit decision in Ariosa v. Sequenom offers further clarification on the scope of patent-eligible subject matter
USA - June 23 2015 On June 12, 2015, the Federal Circuit issued its eagerly anticipated decision in Ariosa v. Sequenom, which assessed the subject matter eligibility of…
